Astellas Announces FDA Approval of ASTAGRAF XL™ (tacrolimus extended … – Yahoo! News
|
Astellas Announces FDA Approval of ASTAGRAF XL™ (tacrolimus extended …
Yahoo! News … Administration (FDA) has approved ASTAGRAF XLTM (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without … |
